Apexian Pharmaceuticals
apexianpharma.comLocations
Indianapolis, IN, USA
industry
Biotechnology
Size
1 - 10 employees
Stage
Other
founded in
2005
Apex Therapeutics is an emerging clinical-stage biotechnology company founded on the scientific discoveries of Dr. Mark R. Kelley, whose groundbreaking work on APE1/Ref-1 redox protein signaling at the Indiana University School of Medicine has provided a unique insight into this novel biological target. It was founded in 2005 and headquartered in Indianapolis, Indiana.
Is this your company?
If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the Elevate Ventures network.
Something looks off?
Open jobs at Apexian Pharmaceuticals
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.